发明名称 |
CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA |
摘要 |
CRF1 receptor antagonists have the potential to directly inhibit ACTH release in patients with CAH and thereby allow normalization of androgen production while using lower, more physiologic doses of hydrocortisone, and thus reducing treatment-associated side effects. |
申请公布号 |
CA2936974(A1) |
申请公布日期 |
2015.07.30 |
申请号 |
CA20152936974 |
申请日期 |
2015.01.21 |
申请人 |
NEUROCRINE BIOSCIENCES, INC. |
发明人 |
GRIGORIADIS, DIMITRI E. |
分类号 |
A61K31/427;A61K31/4985;A61K31/519 |
主分类号 |
A61K31/427 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|